Grown Rogue International (GRUSF) Net Margin (2009 - 2026)

Grown Rogue International's (GRUSF) quarterly Net Margin came in at 1.09% in Q1 2026, down 103.04% quarter-over-quarter from 35.85% in Q4 2025.

Grown Rogue International (GRUSF) Net Margin (2009 - 2026) Analysis & Trends

Grown Rogue International's Net Margin history runs 16 years deep, the most recent figure standing at 1.09% for Q1 2026.

  • On a quarterly basis, Net Margin changed N/A year-over-year to 1.09% in Q1 2026; TTM through Mar 2026 was 57.67%, a 7161.0% increase from a year earlier, with the FY2025 full-year figure at 1.4%, down 45.0% from the prior year.
  • Net Margin slipped to 1.09% in Q1 2026 per GRUSF's latest filing, from 35.85% in the prior quarter.
  • Across five years, Net Margin topped out at 50.31% in Q3 2025 and bottomed at 99.62% in Q2 2024.
  • The 5-year median for Net Margin is 0.83% (2023), against an average of 0.17%.
  • Across the five-year window, Net Margin soared 3190 bps in 2023 and jumped 9962 bps in 2025, its largest moves.
  • Year by year, Net Margin stood at 11.33% in 2022, then jumped by 263 bps to 18.48% in 2023, then slumped by 162 bps to 11.42% in 2024, then soared by 414 bps to 35.85% in 2025, then sank by 103 bps to 1.09% in 2026.
  • Per Business Quant, the three latest GRUSF Net Margin figures stand at 1.09% (Q1 2026), 35.85% (Q4 2025), and 50.31% (Q3 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Margin (Qtr)
1 Haleon 87.22 Bn 85.35 Bn - -
2 Teva Pharmaceutical Industries 39.60 Bn 35.87 Bn 1.97 Bn 9.29%
3 Zoetis 31.46 Bn 29.52 Bn 1.62 Bn 26.57%
4 Takeda Pharmaceutical 26.49 Bn 22.44 Bn 4.39 Bn -33.66%
5 United Therapeutics 23.03 Bn 20.88 Bn 648.10 Mn 35.18%
6 Universe Pharmaceuticals 23.03 Bn -10.56 Bn - -
7 Viatris 20.90 Bn 19.09 Bn 1.16 Bn 5.03%
8 Neurocrine Biosciences 17.50 Bn 16.19 Bn 800.70 Mn 24.30%
9 Elanco Animal Health 12.33 Bn 11.91 Bn 785.00 Mn 4.16%
10 Grown Rogue International 99.97 Mn 92.67 Mn 3.96 Mn -1.09%

Historic Data

Download Data
DateValue
Mar 31, 2026 -1.09%
Dec 31, 2025 35.85%
Sep 30, 2025 50.31%
Jun 30, 2025 0.00%
Sep 30, 2024 -11.42%
Jun 30, 2024 -99.62%
Dec 31, 2023 18.48%
Oct 31, 2023 -8.26%
Jul 31, 2023 1.67%
Apr 30, 2023 6.88%
Jan 31, 2023 20.57%
Jan 31, 2022 -11.33%
Jul 31, 2021 -1.80%
Apr 30, 2021 -74.48%
Jan 31, 2021 -102.42%
Oct 31, 2020 2.49%
Jul 31, 2020 -88.30%
Apr 30, 2020 -109.95%
Jan 31, 2020 -145.43%
Oct 31, 2019 -483.63%